Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
SAN DIEGO--(BUSINESS WIRE)--Researchers at Inocras, a bioinformatics-led precision health company harnessing the power of whole-genome sequencing (WGS) data and proprietary analytics, and the Broad ...
Association of neighborhood-level factors with access to genetic testing in patients with resectable pancreatic ductal adenocarcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
The first resource containing high-resolution DNA sequencing data for over 37,000 children and parents collected over multiple decades from across the UK is now available to researchers worldwide. The ...
Scientists at the Baylor College of Medicine and collaborating institutions used complementary approaches that integrate exome sequencing and evolutionary action machine learning to identify protein ...
Effectiveness of a multidomain mHealth-based intervention in enhancing recovery and quality of life for esophageal cancer patients undergoing esophagectomy. The lost evidence: A phase III, multicenter ...
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...
Inocras and Broad Institute Researchers Will Release Novel Insights From TCGA Cancer Whole-Genome Analysis at AACR Annual Meeting 2026, Empowering a New Era of Precision Oncology Comprehensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results